Abstract 4140910: New-onset Atrial Fibrillation and Associated Long-Term Cardiovascular Morbidity and Mortality in Patients with Type 2 Diabetes Mellitus; A Meta-analysis of 16 million patients.

Circulation, Volume 150, Issue Suppl_1, Page A4140910-A4140910, November 12, 2024. Background:Patients with type 2 diabetes mellitus (T2DM) often develop atrial fibrillation. Nevertheless, its incidence and long-term cardiovascular outcomes in newly diagnosed atrial fibrillation in patients with T2DM are still unclear.Hypothesis:We aim to investigate the association between new-onset AF and the risks of atherosclerotic cardiovascular disease (ASCVD); heart failure (HF), stroke, and all-cause mortality among patients with T2DM.Methods:A systematic search was conducted using multiple electronic databases from inception until March 2024 using the appropriate Mesh terms, “atrial fibrillation,” “diabetes mellitus,” “stroke,” “heart failure,” and “all-cause mortality.” We used the random effect model to calculate the pooled relative risk and their corresponding confidence interval. A p-value of

Leggi
Novembre 2024